1. Home
  2. Category
  3. Symptoms/Side Effects

Oncologic Emergencies

Article

Photography in Telemedicine: Improving Diagnosis of Chronic Graft-Versus-Host Disease

Brianna Busby
Shannon Campbell
Rachel Cole
Charisse DeVries
Kamille Dobbins
Mary Beth Trimble
Mihkaila Wickline
CJON 2017, 21(1), 86-92 DOI: 10.1188/17.CJON.86-92
Background: The long-term follow-up (LTFU) team at the Seattle Cancer Care Alliance uses telemedicine to diagnose and treat post-transplantation complications in hematopoietic cell transplantation (HCT) survivors. Photos are often requested via the telemedicine service to aid in diagnosis, but they...
0
No votes yet
Read this Article
Journal Club Article
Open Access Article

Implementing the Surviving Sepsis Campaign in an Ambulatory Clinic for Patients With Hematologic Malignancies

Brenda K. Shelton
Julie Stanik-Hutt
Joyce Kane
Richard J. Jones
CJON 2016, 20(3), 281-288 DOI: 10.1188/16.CJON.281-288
Background: Infectious complications can occur in patients receiving cancer treatment and are the most common cause of death not directly related to malignancy. Established international best practices for recognition and management of early sepsis with bundled interventions reduce sepsis-related...
0
No votes yet
Read this Article
CJON Writing Mentorship Article

Early Recognition and Management of Posterior Reversible Encephalopathy Syndrome: A Newly Recognized Complication in Patients Receiving Tyrosine Kinase Inhibitors

Ashley Przybylyski
Peg Esper
CJON 2016, 20(3), 305-308 DOI: 10.1188/16.CJON.305-308
Background: Adult patients with cancer receiving antineoplastic, targeted, and other immunosuppressive therapies are at risk for severe side effects. Studies link posterior reversible encephalopathy syndrome (PRES) with immunosuppressants used for patients undergoing transplantation, as well as...
0
No votes yet
Read this Article
Article

Preventing Tumor Lysis Syndrome: Two Case Studies of Unexpected Outcomes

Martha R. Sleutel
William Brown
Jo Nell Wells
CJON 2016, 20(2), 195-200 DOI: 10.1188/16.CJON.195-200
Background: Tumor lysis syndrome (TLS) is a potentially fatal complication in patients with large, rapidly proliferating tumor cell cancers that may occur after chemotherapy. Patients with TLS are complicated to treat and often have an unpredictable trajectory. Objectives: The purpose of this...
3
Average: 3 (1 vote)
Read this Article
Online Exclusive Article

Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab

Keith Dawson
Mollie Moran
Kathleen Guindon
Hui Wan
CJON 2016, 20(2), E41-E48 DOI: 10.1188/16.CJON.E41-E48
Background: In patients with previously untreated chronic lymphocytic leukemia (CLL) and comorbidities, treatment with the glycoengineered, type II anti-CD20 monoclonal antibody obinutuzumab (Gazyva®) (GA101) plus chlorambucil (Leukeran®) was associated with superior outcomes to rituximab (Rituxan...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.